ORGANIGRAM GLOBAL INC.

Organigram Global Inc.

Drug Manufacturers - Specialty & Generic • Healthcare • Toronto, ON, United States • OGI (NMS)

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.

844 644 4726 145 King Street West, Toronto, ON M5H 1J8, Canada

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Organigram Extends Innovation Investment with Phylos - Business Wire
Business Wire • Dec 31
How Investors May Respond To Organigram Global (TSX:OGI) 2025 Loss And 2026 Revenue Guidance Above CAD 300 Million - Yahoo Finance
Yahoo Finance • Dec 21
Organigram: Premium Pivot Signals Further Margin Expansion (NASDAQ:OGI) - Seeking Alpha
Seeking Alpha • Dec 22
Organigram (NASDAQ: OGI) net revenue $259M, sees 2026 above $300M - Stock Titan
Stock Titan • Dec 16
Organigram Holdings Is Suddenly Everywhere — But Is OGI Stock Actually Worth the Hype? - AD HOC NEWS
AD HOC NEWS • Jan 3

Other Drug Manufacturers - Specialty & Generic Companies

View All →
Elanco Animal Health Inc logo Elanco Animal Health Inc.
1 layoff tracked
$11.23B market cap
Zoetis Inc. logo Zoetis Inc.
$55.83B market cap
Galderma Group AG/ADR logo Galderma Group AG
$49.28B market cap
TAKEDA PHARMACEUTICAL CO LTD logo Takeda Pharmaceutical Co. Ltd.
$47.02B market cap
Haleon plc logo Haleon PLC
$44.93B market cap
TEVA PHARMACEUTICAL INDUSTRIES LTD logo TEVA Pharmaceutical Industries Ltd.
$32.82B market cap

Frequently Asked Questions

Has ORGANIGRAM GLOBAL INC. had layoffs?
No layoff events have been recorded for ORGANIGRAM GLOBAL INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does ORGANIGRAM GLOBAL INC. have?
ORGANIGRAM GLOBAL INC. has approximately 1,139 employees.
What industry is ORGANIGRAM GLOBAL INC. in?
ORGANIGRAM GLOBAL INC. operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is ORGANIGRAM GLOBAL INC. a publicly traded company?
Yes, ORGANIGRAM GLOBAL INC. is publicly traded under the ticker symbol OGI on the NMS. The company has a market capitalization of approximately $0.23 billion.
Where is ORGANIGRAM GLOBAL INC. headquartered?
ORGANIGRAM GLOBAL INC. is headquartered in Toronto, ON, United States at 145 King Street West, Toronto, ON M5H 1J8, Canada.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.